Diamyd, Medical

Diamyd Medical highlights opportunity in Type 1 Diabetes prevention, adult-onset market, and upcoming Phase 3 readout

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Diamyd Medical AB Sweden

en | boerse | 67925660 |